HeartSciences Inc. — Form 10-Q
Filed September 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
Andrew Simpson (CEO/Chairman) and Danielle Watson (CFO/Treasurer) certified the July 31, 2026 quarterly report on September 14, 2026 per Sarbanes-Oxley requirements. Both officers attested to the accuracy of financial statements, effectiveness of disclosure controls, and absence of material misstatements or omissions. No specific financial metrics, transactions, or operational changes are disclosed in these certification exhibits.
Why this rating
Boilerplate mandatory SOX certifications containing no substantive business information, financial data, or operational disclosures. Routine regulatory filing requirement.
See more from September 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.